Skip to main content
Expensive insulins, pen devices dominate U.S. diabetes care
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Expensive insulins, pen devices dominate U.S. diabetes care
User login
Username
Password
Reset your password
Concept
Lead
score
Type 2 Diabetes Mellitus
1
1
Diabetes Insipidus
0
1
Shared Decision-Making
0
0.45
Biosimilars
0
0.43
Clinician Health and Well-Being
0
0.43
Medical Life
0
0.43
Insulin Analog
0
1
Metabolism
0
0.29
Pandemic
0
0.29
GLP-1 Receptor Agonist
0
0.25
Adherence
0
0.14
Ambulatory Care
0
0.14
Blood
0
0.14
Clinical Guidelines
0
0.14
COVID-19
0
0.14
Endocrinology
0
0.9
Face
0
0.14
Food and Drug Administration (FDA)
0
0.14
Hand
0
0.14
Health Care Cost
0
0.14
Health Care Reform
0
0.14
Health Policy
0
0.14
Heart
0
0.14
Hypoglycemia
0
0.14
Injectable Medications
0
0.14
Lung
0
0.14
Outpatient Clinic
0
0.14
Professional Societies
0
0.14
Receptors
0
0.14
Stress
0
0.14
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Pharmacist
0
1
Medscape Today
0
0.43
Business of Medicine
0
0.39
Public Health & Prevention
0
0.24
Pulmonary Medicine
0
0.23
Cardiology
0
0.14
Infectious Diseases
0
0.14